2021
DOI: 10.1159/000516396
|View full text |Cite
|
Sign up to set email alerts
|

Zuoguiwan Ameliorates Cognitive Deficits and Neuro-Inflammation in Streptozotocin-Induced Alzheimer’s Disease Rats

Abstract: <b><i>Introduction:</i></b> Alzheimer’s disease is the most popular neurodegenerative disorder with no effective drugs to stop the progression. Zuoguiwan (ZGW), a traditional Chinese herbal medicine, has been applied in many diseases. Our study aimed to detect the function and mechanisms of ZGW in Alzheimer’s disease (AD). <b><i>Methods:</i></b> The rat models of AD were established by streptozotocin (STZ), and the function of ZGW on cognitive dysfunction was mea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“… Abstract Intracerebroventricular streptozotocin (ICV-STZ) injection is among the best animal models to simulate sporadic Alzheimer’s disease (AD) (Hoyer, 2002, 2000, 1998; Salkovic-Petrisic and Hoyer, 2007). Brain insulin signaling abnormality (Grünblatt et al, 2007), neurodegeneration (Kamat, 2015), neuroinflammation (Liu et al, 2022), cholinergic damage (Blokland and Jolles, 1993; Roy et al, 2021), mitochondrial dysfunction (C. Correia et al, 2013), genetic abnormality (Chen et al, 2012), respiratory problem (Ebel et al, 2017), oxidative stress (Sharma and Gupta, 2001), gliosis (Rostami et al, 2017), sleep disturbances (Song et al, 2018) associated with cognitive abnormalities seen in ICV-STZ injected rats.…”
mentioning
confidence: 99%
“… Abstract Intracerebroventricular streptozotocin (ICV-STZ) injection is among the best animal models to simulate sporadic Alzheimer’s disease (AD) (Hoyer, 2002, 2000, 1998; Salkovic-Petrisic and Hoyer, 2007). Brain insulin signaling abnormality (Grünblatt et al, 2007), neurodegeneration (Kamat, 2015), neuroinflammation (Liu et al, 2022), cholinergic damage (Blokland and Jolles, 1993; Roy et al, 2021), mitochondrial dysfunction (C. Correia et al, 2013), genetic abnormality (Chen et al, 2012), respiratory problem (Ebel et al, 2017), oxidative stress (Sharma and Gupta, 2001), gliosis (Rostami et al, 2017), sleep disturbances (Song et al, 2018) associated with cognitive abnormalities seen in ICV-STZ injected rats.…”
mentioning
confidence: 99%